@article{TaniniPecchiIgnat’evetal.2022,
  author    = {Tanini, Damiano and Pecchi, Tommaso and Ignat'ev, Nikolai V. and Capperucci, Antonella},
  title     = {Ionic liquids-assisted ring opening of three-membered heterocycles with thio- and seleno-silanes},
  series = {Catalysts},
  volume    = {12},
  journal   = {Catalysts},
  number    = {10},
  issn      = {2073-4344},
  doi       = {10.3390/catal12101259},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-290350},
  year      = {2022},
  abstract  = {Ring opening reactions of strained heterocycles (epoxides, aziridines, thiiranes) by silyl chalcogenides, such as thiosilanes and selenosilanes, can be efficiently performed in a variety of ionic liquids, which can behave as reaction media and in some cases also as catalysts. This protocol enables an alternative access to β-functionalized sulfides and selenides under mild conditions.},
  language  = {en}
}
@article{ZottnickSprengerFinzeetal.2021,
  author    = {Zottnick, Sven H. and Sprenger, Jan A. P. and Finze, Maik and M{\"u}ller-Buschbaum, Klaus},
  title     = {Statistic Replacement of Lanthanide Ions in Bis-salicylatoborate Coordination Polymers for the Deliberate Control of the Luminescence Chromaticity},
  series = {ChemistryOpen},
  volume    = {10},
  journal   = {ChemistryOpen},
  number    = {2},
  doi       = {10.1002/open.202000251},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-239953},
  pages     = {164 -- 170},
  year      = {2021},
  abstract  = {Based on the strand-like coordination polymer (CP) type \(^{1}\)\(_{∞}\)[Ln(BSB)\(_{3}\)(py)\(_{2}\)], [BSB]-=bis-salicylatoborate anion, mixed Eu/Tb-containing compounds of the constitution \(^{1}\)\(_{∞}\)[Eu\(_{x}\)Tb\(_{1-x}\)(BSB)\(_{3}\)(py)\(_{2}\)] were synthesised ionothermally for a phase width of (x=0.25-0.75) and characterized regarding structure and optical properties. Previously, known only for other lanthanides, the mixed 1D-Eu/Tb-CPs show excellent options for statistic replacement of the Ln-cations during synthesis yielding solid solutions. The products are highly luminescent, with the chromaticity being a direct function of the amount of the respective Ln-ions. Corresponding to an overall addition of emission intensities, the green Tb\(^{3+}\) emission and the red Eu\(^{3+}\) emission allow for a chromaticity control that also includes yellow emission. Control of the luminescence colour renders them suitable examples of the versatility of statistic replacement of metal ions in coordination chemistry. In addition, crystallization of [EMIm]\(_{2}\)[YCl\(_{5}\)(py)] illuminates possible other products of the ionothermal reactions of [EMIm][BSB] with LnCl\(_{3}\) constituted by components not being part of the main CPs.},
  language  = {en}
}
@article{DrischBischoffSprengeretal.2020,
  author    = {Drisch, Michael and Bischoff, Lisa A. and Sprenger, Jan A. P. and Hennig, Philipp T. and Wirthensohn, Raphael and Landmann, Johannes and Konieczka, Szymon Z. and Hailmann, Michael and Ignat'ev, Nikolai V. and Finze, Maik},
  title     = {Innovative Syntheses of Cyano(fluoro)borates: Catalytic Cyanation, Electrochemical and Electrophilic Fluorination},
  series = {Chemistry - A European Journal},
  volume    = {26},
  journal   = {Chemistry - A European Journal},
  number    = {50},
  doi       = {10.1002/chem.202002324},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-216027},
  pages     = {11625 -- 11633},
  year      = {2020},
  abstract  = {Different types of high-yield, easily scalable syntheses for cyano(fluoro)borates Kt[BF\(_{n}\)(CN)\(_{4-n}\)] (n=0-2) (Kt=cation), which are versatile building blocks for materials applications and chemical synthesis, have been developed. Tetrafluoroborates react with trimethylsilyl cyanide in the presence of metal-free Br{\o}nsted or Lewis acid catalysts under unprecedentedly mild conditions to give tricyanofluoroborates or tetracyanoborates. Analogously, pentafluoroethyltrifluoroborates are converted into pentafluoroethyltricyanoborates. Boron trifluoride etherate, alkali metal salts, and trimethylsilyl cyanide selectively yield dicyanodifluoroborates or tricyanofluoroborates. Fluorination of cyanohydridoborates is the third reaction type that includes direct fluorination with, for example, elemental fluorine, stepwise halogenation/fluorination reactions, and electrochemical fluorination (ECF) according to the Simons process. In addition, fluorination of [BH(CN)\(_{2}\){OC(O)Et}]\(^{-}\) to result in [BF(CN)\(_{2}\){OC(O)Et}]\(^{-}\) is described.},
  language  = {en}
}
@phdthesis{Terveer2017,
  author    = {Terveer, Nils},
  title     = {Springs and Parachutes - Development and Characterization of Novel Formulations for Poorly Water-Soluble Drugs},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-154311},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2017},
  abstract  = {Successful formulation development of novel, particularly organic APIs of low molecular weight as candidates for ground-breaking pharmaceutical products is a major challenge for the pharmaceutical industry because of the poor aqueous solubility of most of these compounds. The hit identification strategies of drug development in use today apply high throughput screening techniques for the investigation of thousands of substances. This approach led to a systematical increase in molecular weight and lipophilicity and a decrease of water solubility of lead compounds reaching market access. The high lipophilicity causes an excellent permeability of the compounds which favours the absorption process from the small intestine, but it causes a decrease of water-solubility. It becomes evident that an adequate aqueous solubility is necessary for absorption of the API from the gastrointestinal fluids into the systemic circulation and hence for efficacy of the pharmaceutical product. Only an dissolved API is getting absorbed and becomes efficacious. The precipitated proportion is resigned directly. Therefore, the development of an individual formulation aligning the physicochemical characteristics is necessary for every API to produce supersaturated solutions in the small intestine and to reach an adequate bioavailability after absorption into the systemic circulation. In this thesis a specific formulation development was investigated for two exemplary poorly water-soluble APIs to replace the empirical approach often used today. The basic tyrosine-kinase inhibitor imatinib and six different acetylated amino acids were transferred into ILs. As compared to the free base and the mesylate salt, which is marketed by Novartis AG as Gleevec®, the dissolution rate as well as the supersaturation time was increased significantly. By changing the mesylate anion with its potential genotoxic risks, the total toxicity of the drug product could be decreased. The amorphous ILs proved adequate stability under forcing conditions and there was no recrystallization of the free base observed. The amorphous character of the ILs caused an increased amount of water vapour sorption which can be compensated by special packaging materials. Taken together, the presentation of imatinib as an IL is intended for oral administration as a tablet and can cause a reduction of dose because of the increased solubility. Therefore, the occurrence of side effects can be reduced as compared to Gleevec®. If there is actually an increased bioavailability to observe, has to be proved by the execution of animal trials. The novel NOX inhibitor VAS3947 is intended for the treatment of endothelial dysfunctions causing diseases like heart failure and stroke. The compounds poor aqueous solubility hindered further clinical development so far and make the drug candidate to remain in a very early stage of the drug development process. Therefore, different formulation concepts were evaluated in this study: An amorphous solid dispersion prepared from VAS3947 and Eudragit® L100 by means of spray drying was able to increase the dissolution rate and solubility of the compound significantly, but with the accomplished kinetic solubility being in the low µM range it is not possible to reach therapeutic plasma concentrations. In contrast, the incorporation into cyclodextrins resulted in an 760-fold increased solubility. Different cyclodextrins were evaluated. Especially the lipophilic derivatives of the β-cyclodextrin showed to be the most adequate excipients. The incorporation of the API into the cyclodextrin cavity was proved by means of NMR spectroscopy. Additionally, a formulation of VAS3947 and hydroxypropyl-β-cyclodextrin was prepared. This formulation is intended for the intravenous application during animal trials, which have to be conducted to get to know the pharmacokinetics of VAS3947. This formulation reached a concentration of 1 mg/mL spending striking protection of VAS3947 against degradation. Presentation of VAS3947 as a microemulsion system led also to increase the aqueous solubility of the compound, but not in the same extent as the cyclodextrin formulation. Beside the formulation development a physicochemical characterization was performed to get to know important parameters such as log P and pKa values of VAS3947. An HPLC method was developed and validated to analyse the extent of solubility improvement. A major issue of the compound VAS3947 and all related triazolopyrimidine derivatives, developed by Vasopharm GmbH, is the insufficient chemical stability because of presence of a hemiaminal moiety in the chemical structure. Stability investigations and an extensive biopharmaceutical characterization confirm the hindering of further clinical development by insufficient drug stability and high cytotoxicity. Poor aqueous solubility is an additional disadvantage which can be handled by a concerted formulation development.},
  language  = {en}
}